======= BDH2 ======= == Gene Information == * **Official Symbol**: BDH2 * **Official Name**: 3-hydroxybutyrate dehydrogenase 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=56898|56898]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9BUT1|Q9BUT1]] * **Interactions**: [[https://thebiogrid.org/search.php?search=BDH2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20BDH2|Open PubMed]] * **OMIM**: N/A == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Dehydrogenase that mediates the formation of 2,5- dihydroxybenzoic acid (2,5-DHBA), a siderophore that shares structural similarities with bacterial enterobactin and associates with LCN2, thereby playing a key role in iron homeostasis and transport. Also acts as a 3-hydroxybutyrate dehydrogenase (By similarity). {ECO:0000250, ECO:0000269|PubMed:16380372}. |adh short| |siderophore biosynthetic process| |siderophore metabolic process| |3-hydroxybutyrate dehydrogenase activity| |oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor| |ketone body biosynthetic process| |cellular ketone body metabolic process| |ketone body metabolic process| |nonribosomal peptide biosynthetic process| |secondary metabolite biosynthetic process| |heme metabolic process| |porphyrin-containing compound metabolic process| |NAD binding| |secondary metabolic process| |fatty acid beta-oxidation| |tetrapyrrole metabolic process| |pigment metabolic process| |fatty acid oxidation| |lipid oxidation| |iron ion homeostasis| |fatty acid derivative biosynthetic process| |fatty acid catabolic process| |monocarboxylic acid catabolic process| |transition metal ion homeostasis| |fatty acid derivative metabolic process| |cellular lipid catabolic process| |lipid modification| |cofactor biosynthetic process| |organic acid catabolic process| |carboxylic acid catabolic process| |lipid catabolic process| |fatty acid metabolic process| |peptide biosynthetic process| |generation of precursor metabolites and energy| |small molecule catabolic process| |cofactor metabolic process| |drug metabolic process| |amide biosynthetic process| |peptide metabolic process| |monocarboxylic acid metabolic process| |small molecule biosynthetic process| |metal ion homeostasis| |epithelial cell differentiation| |cation homeostasis| |inorganic ion homeostasis| |ion homeostasis| |cellular amide metabolic process| |carboxylic acid metabolic process| |cellular lipid metabolic process| |oxidation-reduction process| |oxoacid metabolic process| |organic acid metabolic process| |chemical homeostasis| |epithelium development| |lipid metabolic process| |mitochondrion| |organonitrogen compound biosynthetic process| |cellular nitrogen compound biosynthetic process| |homeostatic process| |small molecule metabolic process| |tissue development| |organic substance catabolic process| |cellular catabolic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp472|CI-1040 9.5μM R08 exp472]]|-1.71| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 13909 * **Expression level (log2 read counts)**: 5.18 {{:chemogenomics:nalm6 dist.png?nolink |}}